SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-218018
Filing Date
2022-08-11
Accepted
2022-08-11 08:04:32
Documents
13
Period of Report
2022-08-11
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d385975d8k.htm   iXBRL 8-K 23980
2 EX-99.1 d385975dex991.htm EX-99.1 18245
  Complete submission text file 0001193125-22-218018.txt   173988

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA sldb-20220811.xsd EX-101.SCH 2860
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE sldb-20220811_lab.xml EX-101.LAB 18738
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE sldb-20220811_pre.xml EX-101.PRE 11710
7 EXTRACTED XBRL INSTANCE DOCUMENT d385975d8k_htm.xml XML 3473
Mailing Address 500 RUTHERFORD AVENUE CHARLESTOWN MA 02129
Business Address 500 RUTHERFORD AVENUE CHARLESTOWN MA 02129 617-337-4680
Solid Biosciences Inc. (Filer) CIK: 0001707502 (see all company filings)

IRS No.: 900943402 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38360 | Film No.: 221153765
SIC: 2836 Biological Products, (No Diagnostic Substances)